Lubiprostone for the treatment of opioid-induced bowel dysfunction.

Lubiprostone for the treatment of opioid-induced bowel dysfunction.

Item
http://www.wikidata.org/entity/Q37850804
Evolving paradigms in the treatment of opioid-induced bowel dysfunctionOpioid-induced constipation: pathophysiology, clinical consequences, and management.Overview and treatment of opioid-induced constipation.Lubiprostone in constipation: clinical evidence and place in therapy.A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.Design, synthesis, and biological evaluation of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives as peripheral selective μ opioid receptor Agents.Opioid-induced bowel dysfunction: pathophysiology and management.Achieving effective control in cancer pain: a review of current guidelines.New Options in Constipation Management.Management of opioid-induced constipation in pregnancy: a concise review with emphasis on the PAMORAs.Methadone but not morphine inhibits lubiprostone-stimulated Cl- currents in T84 intestinal cells and recombinant human ClC-2, but not CFTR Cl- currents.Long-Term Safety and Efficacy of Lubiprostone in Opioid-induced Constipation in Patients with Chronic Noncancer Pain.The in vivo pharmacodynamics of the novel opioid receptor antagonist, TD-1211, in models of opioid-induced gastrointestinal and CNS activity.Oral methylnaltrexone is efficacious and well tolerated for the treatment of opioid-induced constipation in patients with chronic noncancer pain receiving concomitant methadone
P2860

Lubiprostone for the treatment of opioid-induced bowel dysfunction.

Item
http://www.wikidata.org/entity/Q37850804
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lubiprostone for the treatment of opioid-induced bowel dysfunction.
@en
Lubiprostone for the treatment of opioid-induced bowel dysfunction.
@nl
type
label
Lubiprostone for the treatment of opioid-induced bowel dysfunction.
@en
Lubiprostone for the treatment of opioid-induced bowel dysfunction.
@nl
prefLabel
Lubiprostone for the treatment of opioid-induced bowel dysfunction.
@en
Lubiprostone for the treatment of opioid-induced bowel dysfunction.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Lubiprostone for the treatment of opioid-induced bowel dysfunction.
@en
P2093
P2860
P304
P31
P356
10.1517/14656566.2011.566559
P407
P433
P478
P50
P577
P698
P921